IP Library Granted Patent US 7,202,075
Granted Patent B2
US 7,202,075 · App. 10/940,954 · Granted Apr 10, 2007

Isolated protein having hydroxynitrile lyase activity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,202,075
App. No.
10/940,954
Granted
Apr 10, 2007
Kind
B2
Abstract

New genes containing a DNA sequence coding for hydroxynitrile lyase, which genes can be prepared via a primer combination based on the DNA sequence of the 5′-region of the mdl genes from the Prunus serotina and from Prunus amygdalus and/or a primer 2 based on the 3′-region of the DNA sequences of one of the hydroxynitrile lyase isoenzymes from Prunus serotina or from Prunus amygdalus , subsequent amplification with a DNA polymerase using a DNA from organisms, containing genes coding for hydroxynitrile lyase, as templates and cloning, and also recombinant proteins which can be prepared in suitable host cells by heterologous expression of the DNA sequence of said HNL genes, and proteins and fusion proteins derived therefrom and use of said proteins for preparing (R)- or (S)-cyanohydrins.

Claims (21)

1. An isolated protein having hydroxynitrile lyase activity selected from the group consisting of:

(1) a protein having hydroxynitrile lyase activity comprising the amino acid sequence of SEQ ID NO: 20;

(2) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 19;

(3) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having at least 85% identity with the nucleic acid sequence of SEQ ID NO: 19;

(4) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence from nucleotide 13 to nucleotide 2151 of SEQ ID NO: 19; and

(5) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 19 without the intron regions of nucleotides 116 to nucleotide 257, nucleotide 918 to nucleotide 1120, or nucleotide 1962 to nucleotide 2077.

2. The isolated protein of claim 1 , wherein the protein is recombinantly produced.

3. The recombinant protein of claim 2 which is obtained by heterologous expression.

4. The recombinant protein of claim 2 , which comprises host-specific glycosylation.

5. The recombinant protein of claim 2 , wherein the protein is prepared by expression in an eukaryotic microorganism.

6. The recombinant protein of claim 2 , wherein said protein is prepared by expression in a fungus.

7. An isolated fusion protein or heterologous protein having hydroxynitrile lyase activity selected from the group consisting of:

(1) a protein having hydroxynitrile lyase activity having the amino acid sequence of SEQ ID NO: 22; and

(2) a protein having hydroxynitrile lyase activity encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 21 having the 5′ and 3′ terminal portions of the nucleotide sequence encoding Aspergillus niger glucose oxidase protein.

8. An isolated protein having hydroxynitrile lyase activity selected from the group consisting of:

(1) a protein having the amino acid sequence of SEQ ID NO: 24; and

(2) a protein encoded by a nucleotide sequence having the nucleic acid sequence of SEQ ID NO: 23.

9. A method for producing (R)- or (S)-cyanohydrins comprising contacting the protein having hydroxynitrile lyase activity of claim 1 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor.

10. A method for producing (R)- or (S)-cyanohydrins comprising contacting the recombinant protein having hydroxynitrile lyase activity of claim 2 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor.

11. A method for producing (R)- or (S)-cyanohydrins comprising contacting the fusion protein or heterologous protein having hydroxynitrile lyase activity of claim 7 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor.

12. A method for producing (R)- or (S)-cyanohydrins comprising contacting the protein having hydroxynitrile lyase activity of claim 8 with aliphatic, aromatic or heteroaromatic aldehydes and ketones in an organic, aqueous or 2-phase system or in emulsion in the presence of a cyanide group donor.

Assignments (3)
RELEASE (REEL 032424 / FRAME 0001) Recorded Sep 28, 2017
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG
Reel/Frame 044037/0879 →
NOTICE OF SUCCESSION OF AGENCY FOR PATENT SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (032424/0001) Recorded Jul 12, 2017
From: UBS AG, STAMFORD BRANCH, AS PRIOR AGENT
To: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH, AS SUCCESSOR AGENT
Reel/Frame 043165/0987 →
SECURITY INTEREST Recorded Mar 11, 2014
From: DSM FINE CHEMICALS AUSTRIA NFG GMBH & COKG
To: UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT
Reel/Frame 032424/0001 →